Mirum Pharmaceuticals: Citigroup raises target price to $160 from $145
MIRM•Citigroup raised its target price for Mirum Pharmaceuticals to $160 from $145.
Related News
Xanadu partners with Bluefors on modular cryogenic prototype for utility-scale quantum computing
XNDU•
AstraZeneca strikes clinical collaboration with Summit to test ADC sonesitatug vedotin with ivonescimab in GI cancers
AZN•
Invivyd says LIBERTY Phase 3 trial shows VYD2311 safety, tolerability top mRNA COVID-19 vaccine
IVVD•
Scholastic to acquire Cottage Door Press for about $71 million
SCHL•
Jefferies Financial Group target price cut to $50 from $57
JEF•